Treatment strategies against triple-negative breast cancer: an updated review
Triple-negative breast cancer (TNBC) is associated with an increased risk of early
recurrence and distant metastasis, as well as the development of therapeutic resistance and …
recurrence and distant metastasis, as well as the development of therapeutic resistance and …
Circulating tumor cell isolation, culture, and downstream molecular analysis
S Sharma, R Zhuang, M Long, M Pavlovic, Y Kang… - Biotechnology …, 2018 - Elsevier
Circulating tumor cells (CTCs) are a major contributor of cancer metastases and hold a
promising prognostic significance in cancer detection. Performing functional and molecular …
promising prognostic significance in cancer detection. Performing functional and molecular …
Tumor necrosis factor α blockade: an opportunity to tackle breast cancer
MF Mercogliano, S Bruni, PV Elizalde… - Frontiers in …, 2020 - frontiersin.org
Breast cancer is the most frequently diagnosed cancer and the principal cause of mortality
by malignancy in women and represents a main problem for public health worldwide. Tumor …
by malignancy in women and represents a main problem for public health worldwide. Tumor …
RANKL/RANK/OPG system beyond bone remodeling: involvement in breast cancer and clinical perspectives
Abstract RANKL/RANK/OPG system consists of three essential signaling molecules: i) the
receptor activator of nuclear factor (NF)-kB-ligand (RANKL), ii) the receptor activator of NF …
receptor activator of nuclear factor (NF)-kB-ligand (RANKL), ii) the receptor activator of NF …
Targeting the NFκB signaling pathways for breast cancer prevention and therapy
The activation of nuclear factor-kappaB (NFΚB), a proinflammatory transcription factor, is a
commonly observed phenomenon in breast cancer. It facilitates the development of a …
commonly observed phenomenon in breast cancer. It facilitates the development of a …
Curcumin: modulator of key molecular signaling pathways in hormone-independent breast cancer
R Farghadani, R Naidu - Cancers, 2021 - mdpi.com
Simple Summary Breast cancer remains the most commonly diagnosed cancer and the
leading cause of cancer death among females worldwide. It is a highly heterogeneous …
leading cause of cancer death among females worldwide. It is a highly heterogeneous …
Positioning of proteasome inhibitors in therapy of solid malignancies
MSF Roeten, J Cloos, G Jansen - Cancer chemotherapy and …, 2018 - Springer
Targeting of the protein degradation pathway, in particular, the ubiquitin-proteasome system,
has emerged as an attractive novel cancer chemotherapeutic modality. Although …
has emerged as an attractive novel cancer chemotherapeutic modality. Although …
Targeting proteotoxic stress in cancer: a review of the role that protein quality control pathways play in oncogenesis
M Ho Zhi Guang, EL Kavanagh, LP Dunne, P Dowling… - Cancers, 2019 - mdpi.com
Despite significant advances in cancer diagnostics and therapeutics the majority of cancer
unfortunately remains incurable, which has led to continued research to better understand …
unfortunately remains incurable, which has led to continued research to better understand …
Transcription factor NF-κB: an update on intervention strategies
The nuclear factor (NF)-κB family of transcription factors are ubiquitous and pleiotropic
molecules that regulate the expression of more than 150 genes involved in a broad range of …
molecules that regulate the expression of more than 150 genes involved in a broad range of …
Combined drug therapeutic strategies for the effective treatment of Triple Negative Breast Cancer
NKR Chalakur-Ramireddy, SB Pakala - Bioscience reports, 2018 - portlandpress.com
TNBC (Triple Negative Breast Cancer) is a subtype of breast cancer with an aggressive
phenotype which shows high metastatic capability and poor prognosis. Owing to its intrinsic …
phenotype which shows high metastatic capability and poor prognosis. Owing to its intrinsic …